Raising The Bar For New Anticoagulants? Warfarin Genotype Study Finds Reduced Risk
This article was originally published in The Pink Sheet Daily
Executive Summary
Medco/Mayo study links more precise warfarin dosing through genotyping to a 30 percent reduction in hospitalization rates compared with patients not tested prior to starting therapy.